ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
J

ASCO® 2023 Insights: "CONTINUUM Trial Data on Sintilimab + Chemo in High-Risk Locoregionally-Advanced Nasopharyngeal Carcinoma"

By ecancer FEATURING Jun Ma
By ecancer FEATURING Jun Ma
27 views
June 15, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn
ASCO® 2023
06:19
ecancer

2023 ASCO® Insights: "TRANSCEND CLL-004 Study of Liso-cel in R/…

Feat. T. Siddiqi
06:16
ecancer

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem…

Feat. E. O’Reilly
12:16
ecancer

ASCO® 2023 Summary: "Analysis of Key Studies in Lung Cancer - A…

Feat. L. Raez
47:10
ecancer

ASCO® 2023 Summary: "PanTumor Conference Highlights Including I…

Feat. B. Gyawali
06:11
ecancer

ASCO® 2023 Insights: "Key Head & Neck Data"

Feat. G. Hanna
05:47
ecancer

ASCO® 2023 Insights: "Results From WF-1804CD Study on Effective…

Feat. K. Weaver
05:49
ecancer

ASCO® 2023 Insights: "CONTINUUM Trial Data on Sintilimab + Chem…

Feat. J. Ma
03:44
ecancer

ASCO® 2023 Insights: "Concurrent CRT Followed by Adjuvant Cispl…

Feat. L. Tang
19:47
ecancer

ASCO® 2023 Summary: "Current Treatment Landscape for Advanced B…

Feat. A. Siefker-Radtke, Y. Loriot
23:57
ecancer

ASCO® 2023 Summary: "Key Trials in mRCC"

Feat. J. Puente, C. Suárez, S. Oudard, V. Grünwald
04:59
ecancer

ASCO® 2023 Insights: "SWOG S1011 Trial - Standard vs. Extended …

Feat. S. Lerner
03:07
ecancer

ASCO® 2023 Insights: "Randomised Phase II Trial of Cabozantinib…

Feat. B. Van Tine
03:49
ecancer

ASCO® 2023 Insights: "IMbrave050 Data on Atezolizumab + Bevaciz…

Feat. M. Kudo
04:02
ecancer

ASCO® 2023 Insights: "New Data From KEYNOTE-942 on DMFS With Ad…

Feat. M. Adnan Khattak
08:30
ecancer

ASCO® 2023 Insights: "PRODIGE 23 Trial on Neoadjuvant Chemo + m…

Feat. T. Conroy
02:19
ecancer

ASCO® 2023 Insights: "KEYNOTE-716 Results on Pembro Use in Stag…

Feat. J. Luke
04:07
ecancer

ASCO® 2023 Insights: "2L Triple Metronomic Chemo vs. Systemic T…

Feat. R. Kiran Kothari
04:10
ecancer

ASCO® 2023 Insights: "PHERGain Data on Dual HER2 Blockade Witho…

Feat. J. Cortes
02:22
ecancer

ASCO® 2023 Insights: "ATTRACTION-5 Study on Nivo + Chemo as Pos…

Feat. M. Terashima
05:02
ecancer

ASCO® 2023 Insights: "Short-HER Data on Nine-Weeks vs. One-Year…

Feat. P. Conte
04:21
ecancer

ASCO® 2023 Insights: "SONIA Trial Summary on 1L Use of CDK4/6i …

Feat. G. Sonke
02:26
ecancer

ASCO® 2023 Insights: "A Systematic Review and Meta-Analysis of …

Feat. C. Molinelli
03:43
ecancer

ASCO® 2023 Insights: "Novel FolRα-Targeting ADC Luveltamab Taze…

Feat. A. Oaknin
03:02
ecancer

ASCO® 2023 Insights: "DESTINY-PanTumor02 Data on T-DXd Response…

Feat. F. Meric-Bernstram
02:05
ecancer

ASCO® 2023 Insights: "RUBY Trial Summary on Dostarlimab + Chemo…

Feat. M. Powell
03:44
ecancer

ASCO® 2023 Insights: "Dr. Wakelee on KEYNOTE-671 Study Updates …

Feat. H. Wakelee
03:05
ecancer

ASCO® 2023 Insights: "Phase III NATALEE Trial - Ribociclib + ET…

Feat. D. Slamon
10:06
ecancer

ASCO® 2023 Summary: "Key Studies in Early Breast Cancer"

Feat. M. Lambertini
03:38
ecancer

ASCO® 2023 Insights: "Baseline Liquid Biopsy Results in Treatme…

Feat. S. Stintzing
04:33
ecancer

ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable A…

Feat. P. Bradbury
06:08
ecancer

ASCO® 2023 Insights: "Next-Generation Selective RET Inhibitor i…

Feat. Q. Zhou
03:33
ecancer

ASCO® 2023 Insights: "TRIMM-2 Study Summary - Update on Talquet…

Feat. B. Dholaria
06:50
ecancer

ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. B…

Feat. A. Herrera
04:17
ecancer

ASCO® 2023 Insights: "CARTITUDE-4 Study Summary - Cilta-Cel Vs.…

Feat. B. Dhakal
05:20
ecancer

ASCO® 2023 Insights: "RedirecTT-1 Study Summary - Teclistamab +…

Feat. Y. C. Cohen
05:03
ecancer

ASCO® 2023 Insights: "Elranatamab in Patients With R/R MM Previ…

Feat. A. Nooka
02:39
ecancer

ASCO® 2023 Insights: "ZUMA-7 Study Summary - Axi-Cel in Early R…

Feat. J. Westin
06:59
ecancer

ASCO® 2023 Insights: "Teclistamab for R/R MM - Summary of Long-…

Feat. N. Van De Donk
04:34
ecancer

ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary M…

Feat. E. Zucca
17:11
ecancer

ASCO® 2023 Summary: "Latest in PARPi in Prostate Cancer - PROpe…

Feat. R. McKay, F. Schlürmann, G. von Amsberg
04:14
ecancer

ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fiel…

Feat. T. Leal
05:00
ecancer

ASCO® 2023 Insights: "Phase 3 CONTACT-03 Study - Efficacy &…

Feat. T. Choueiri
04:57
ecancer

FDA Updates: TALAPRO-2 Phase 3 Study - Talazoparib + Enzalutamide in…

Feat. K. Fizazi
04:19
ecancer

ASCO® 2023 Insights: "AI-Derived Digital Pathology-Based Biomar…

Feat. A. Armstrong
01:42
ecancer

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysi…

Feat. R. Herbst